drugset / Trial / NCT00203814

A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria

NCT00203814

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the efficacy of sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine alone in the treatment of uncomplicated malaria.

Timeline

Start
2004-01
Primary completion
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Artesunate Small molecule 4 mg/kg
Subject Sulfadoxine-pyrimethamine Small molecule 1.25 mg/kg
Subject Sulfadoxine-pyrimethamine Small molecule 25 mg/kg